While original functional and genomic studies on BRD4 were performed on NUT midline carcinoma, because of the lower incidence of this disease (as compared to other cancers), diverse scientific opinions exist on a more generalized applicability in other malignancies [94]. This evidence concerns the gene BRD4 and cancer.